ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NXGL vs IVF // ENTERPRISE SCALE & MARKET CAP

NexGel Inc (NASDAQ) VS. INVO Fertility Inc. (NASDAQ) • 15-METRIC TALLY: NXGL 3 — IVF 3
▲ ENTERPRISE SCALE & MARKET CAP LEADER: IVF
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NXGL VS. IVF) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NXGL IVF SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 39.50% 96.00% -56.50 IVF /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -29.30% -60.00% +30.70 NXGL /operating-margins <GO>
Net Profit Margin -26.30% 68.00% -94.30 IVF /net-margins <GO>
Revenue Growth (YoY) 31.50% 4.30% +27.20 NXGL /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 5/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.0 14.3 +28.70 NXGL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $1.9M $2.5M -$575.7K IVF /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NXGL REV IVF REV NXGL GROSS % IVF GROSS % NXGL FCF IVF FCF
FY 2025 $11.4M $6.8M 39.5% 98.0% -$1.4M -$7.1M
FY 2024 $8.7M $6.6M 31.6% 43.3% -$4.3M -$3.2M
FY 2023 $4.1M $3.0M — — -$3.2M -$4.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NXGL // BETA —
IVF // BETA —